🇺🇸 FDA
Patent

US 9238625

Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

granted A61PA61P25/24A61P3/04

Quick answer

US patent 9238625 (Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives) held by REVIVA PHARMACEUTICALS, INC. expires Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REVIVA PHARMACEUTICALS, INC.
Grant date
Tue Jan 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P25/24, A61P3/04